A multicenter prospective evaluation of the benefits of Dexcom ONE + in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study
Acta Diabetologica · 11.04.2026 · 63 (6) · 1057-1066
DOI: 10.1007/s00592-026-02682-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Diabetologica, online erschienen am 11.04.2026. Verfasst von Ana Chico und 12 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Nutrition Department, Hospital Santa Creu i Sant Pau Barcelona, Spain. C/San Quintín 167, 08025, Barcelona, Spain. achicob@santpau.…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology and Nutrition Department, Hospital Santa Creu i Sant Pau Barcelona, Spain. C/San Quintín 167, 08025, Barcelona, Spain. achicob@santpau.cat.
- Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. achicob@santpau.cat.
- Universitat Autònoma de Barcelona, Barcelona, Spain. achicob@santpau.cat.
- CIBER-BBN, Instituto de Salud Carlos III, Madrid, Spain. achicob@santpau.cat.
- Endocrinology and Nutrition Department, Germans Trias i Pujol University Hospital, Badalona, Spain.
- Endocrinology and Nutrition Department, Complex Hospitalari Universitari Moisès Broggi, Sant Joan Despí, Barcelona, Spain.
Zitieren
APA
Chico, A., Aguilera-Hurtado, E., Albareda, M., Moreno-Fernández, J., Beato-Vibora, P., Fernández-Rubio, E., Cuesta, M., Bartual, A., Ampudia-Blasco, F. J., Bandrés, O., Ares, J., Rivero, M. T., & Picón-César, M. J. (2026). A multicenter prospective evaluation of the benefits of Dexcom ONE + in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study. Acta Diabetologica, 63(6), 1057-1066. https://doi.org/10.1007/s00592-026-02682-9
Vancouver
Chico A, Aguilera-Hurtado E, Albareda M, Moreno-Fernández J, Beato-Vibora P, Fernández-Rubio E, et al. A multicenter prospective evaluation of the benefits of Dexcom ONE + in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study. Acta Diabetologica. 2026;63(6):1057-1066. doi:10.1007/s00592-026-02682-9
BibTeX
@article{Chico2026,
author = {Chico, Ana and Aguilera-Hurtado, Eva and Albareda, Mercè and Moreno-Fernández, Jesús and Beato-Vibora, Pilar and Fernández-Rubio, Elsa and Cuesta, Martín and Bartual, Amparo and Ampudia-Blasco, Francisco Javier and Bandrés, Orosia and Ares, Jessica and Rivero, María Teresa and Picón-César, María José},
title = {A multicenter prospective evaluation of the benefits of Dexcom ONE + in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study},
journal = {Acta Diabetologica},
year = {2026},
volume = {63},
number = {6},
pages = {1057--1066},
doi = {10.1007/s00592-026-02682-9}
}
EUVIMED